Angiotensin Therapeutics Inc. announces publication of a study using a soluble ACE2 protein designed for COVID-19
/PRNewswire/ -- Angiotensin Therapeutics Inc. ("Angiotensin" or the "Company"), a privately-held biopharmaceutical company focused on developing new therapies...
Source: prnewswire.com